Primary Care Diagnostics

05/22/2026

In patients with cardiometabolic disease, circulatory decline often begins before overt symptoms appear. The TM Flow System provides clinicians with a practical in-office method to identify these early changes and incorporate objective vascular data into ongoing care.

By detecting reduced perfusion earlier and supporting longitudinal monitoring, the TM Flow System helps strengthen chronic disease management, improve clinical decision-making, and support better long-term outcomes in at-risk patients.

05/15/2026

One of the challenges in dementia evaluation is that early symptoms are often easy to dismiss or difficult to define. A patient may seem mostly functional yet still show subtle decline. A family member may report concerning changes that are not obvious during the visit. In these situations, objective testing can provide valuable support.

The COGNISION® System helps strengthen evaluation by adding measurable brain-function data to the overall assessment. This can help clinicians determine whether closer follow-up, additional workup, or referral is warranted.

05/08/2026

Traditional cardiometabolic monitoring remains essential, but numbers such as A1c, blood pressure, and lipid panels do not always show how disease is affecting tissue perfusion in real time. A patient may appear relatively stable on paper while vascular changes continue to progress.

The TM Flow System helps bridge that gap by providing physiologic information that reflects how circulation is functioning at the point of care. This can support earlier recognition of patients who may need closer follow-up, more aggressive risk reduction, or additional vascular evaluation.

Why early circulatory changes are often missed Cardiometabolic disease rarely begins with a major clinical event. More often, vascular changes develop gradually over time as diabetes, hypertension, obesity, and metabolic syndrome begin to affect circulation long before a patient presents with advanc...

05/01/2026

The COGNISION® System provides in-office ERP and EEG testing designed to support cognitive evaluation through objective physiologic measurement. During testing, patients wear a headset while brain responses to auditory stimuli are recorded. These responses offer insight into neural processing associated with attention and working memory, while resting EEG adds information about background brain activity.

Dementia evaluation is rarely straightforward Evaluating dementia in clinical practice often involves more than identifying memory loss alone. Early cognitive decline may present as slowed thinking, reduced attention, difficulty with working memory, or subtle changes in day-to-day functioning that a...

04/21/2026

Early cognitive decline can be difficult to detect when symptoms are mild or inconsistent. This short video explains how the COGNISION® System helps establish cognitive baselines through in-office ERP and EEG testing, giving providers objective data to support monitoring and earlier dementia detection over time.

04/14/2026

How do you track cardiometabolic risk beyond symptoms and routine lab work? This short video highlights how the TM Flow System provides objective in-office data to support long-term monitoring of vascular and nerve-related changes. It is a practical look at how trending physiologic data can strengthen chronic disease management and help guide earlier intervention.

04/07/2026

Establishing a cognitive baseline can make a meaningful difference when patients begin showing subtle signs of memory or processing changes. In our latest blog, we explore how the COGNISION® System supports baseline brain function testing in patients at risk for dementia through objective ERP and EEG data. These measurements can help clinicians track change over time and support earlier, more confident decision-making. Read the full blog here:

Why Cognitive Baselines Matter Cognitive decline often begins gradually, with subtle changes that may be difficult to detect during routine clinical visits. Patients may report occasional forgetfulness or slowed thinking, but early symptoms can overlap with normal aging or temporary stress. Without....

04/01/2026

Cardiometabolic disease often progresses long before major symptoms appear, which makes ongoing monitoring essential. In our latest blog, we look at how the TM Flow System helps providers track cardiometabolic risk over time through objective vascular and sudomotor data. By identifying trends in circulation and small fiber nerve function, clinicians can gain a clearer picture of improvement, stability, or decline and make more informed care decisions. Read the full blog here:

The Importance of Monitoring Cardiometabolic Health Cardiometabolic disease remains one of the most significant contributors to morbidity and mortality worldwide. Conditions such as diabetes, hypertension, and metabolic syndrome often develop gradually, with physiologic changes occurring long before...

03/20/2026

Objective ERP and EEG data allow you to detect abnormalities in cognitive processing that may not yet be evident on traditional screening tools. When patients present with early cognitive complaints, the COGNISION® System provides physiologic evidence that supports further evaluation, closer monitoring, or referral when appropriate.

This early insight is particularly valuable in patients with risk factors such as diabetes, cardiovascular disease, or family history of dementia.

03/11/2026

The TM Flow System integrates noninvasive vascular and nerve-related measurements into a single assessment. Vascular testing evaluates blood flow to the lower extremities and identifies peripheral arterial disease through objective perfusion values, helping detect vessel blockage that may not yet be clinically obvious.

Sudomotor testing assesses small fiber nerve function by measuring sweat gland activity, which is commonly impaired in neuropathic conditions associated with diabetes and metabolic disease.

When these data points are viewed together, clinicians can determine whether symptoms are primarily driven by vascular insufficiency, neuropathic dysfunction, or both, allowing for more precise clinical decision making.

03/07/2026

Lower extremity symptoms are among the most frequent and challenging complaints in patients with metabolic and cardiovascular disease. By distinguishing neuropathy from vascular blockage and providing ongoing insight into cardiometabolic health, the TM Flow System offers a practical solution for both diagnosis and long-term management.

https://primarycarediagnostics.com/using-the-tm-flow-system-to-differentiate-neuropathy-from-vascular-blockage-in-patients/